| Literature DB >> 30827153 |
Yong-Jun Cao1, Ying Xu2, Bei Liu2, Xi Zheng2, Jian Wu1, Ying Zhang2, Xiao-Si Li2, Yan Qi3, Yu-Meng Sun1, Wei-Bo Wen2, Lifei Hou3, Chun-Ping Wan2.
Abstract
Dioscin, a steroidal saponin isolated from Dioscorea nipponica Makino, has previously been shown to possess antiarthritic effects. However, the underlying mechanism is still elusive. Herein, we investigated the therapeutic effects of dioscin on collagen-induced arthritis (CIA) in DBA/1 mice and related mechanism. Cytokine production in CII-specific immune responses were measured by enzyme-linked immunosorbent assay (ELISA); Th17 cell-related gene expression, including IL-17A, ROR γτ and IL-23p19, were detected by qPCR analysis; Surface marker, T regulatory (Treg) cells and intracellular cytokines (IL-17A and IFN- γ ) were evaluated by flow cytometry. We performed Th17 cell differentiation assay in vitro. Results showed that, in vivo, dioscin treatment significantly reduced the severity of CIA, which was accompanied by decreased Th17 response, but not Th1 and Treg response; dioscin-treated mice also showed lower percentage of CD11b + Gr-1 + neutrophils; In vitro, dioscin treatment suppressed the differentiation of naive CD4 + T cells into Th17 cell and decreased IL-17A production. Collectively, our results indicate that dioscin exerts antiarthritic effects by inhibiting Th17 cell immune response.Entities:
Keywords: Collagen-Induced Arthritis; Dioscin; Rheumatoid Arthritis; T Cell Differentiation; Th17 Cells
Mesh:
Substances:
Year: 2019 PMID: 30827153 DOI: 10.1142/S0192415X19500216
Source DB: PubMed Journal: Am J Chin Med ISSN: 0192-415X Impact factor: 4.667